Heron Therapeutics Announces Cost Reduction Plan and … – PR Newswire
– Expected overall cash savings of $75 million through 2025– New executive management team in place SAN DIEGO, July 24, 2023 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care, today announced a cost reduction plan and…